113 related articles for article (PubMed ID: 3119191)
1. Molecular comparisons of acquired and native mitomycin C resistance in human colon carcinoma cells.
Chakrabarty S; Brattain MG
Cancer Lett; 1987 Nov; 37(3):267-76. PubMed ID: 3119191
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
[TBL] [Abstract][Full Text] [Related]
3. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
[TBL] [Abstract][Full Text] [Related]
4. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
Pan SS; Akman SA; Forrest GL; Hipsher C; Johnson R
Cancer Chemother Pharmacol; 1992; 31(1):23-31. PubMed ID: 1458556
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
Pan SS; Yu F; Hipsher C
Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of cytosolic protein and phosphoprotein changes in human colon tumor cells with the development of resistance to mitomycin C.
Taylor CW; Brattain MG; Yeoman LC
Cancer Res; 1985 Sep; 45(9):4422-7. PubMed ID: 3928156
[TBL] [Abstract][Full Text] [Related]
8. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
Hoban PR; Walton MI; Robson CN; Godden J; Stratford IJ; Workman P; Harris AL; Hickson ID
Cancer Res; 1990 Aug; 50(15):4692-7. PubMed ID: 2114946
[TBL] [Abstract][Full Text] [Related]
9. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Lee JH; Naito M; Tsuruo T
Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.
Pan SS; Forrest GL; Akman SA; Hu LT
Cancer Res; 1995 Jan; 55(2):330-5. PubMed ID: 7812966
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay.
Chan PK; Aldrich MB; Chakrabarty S
Cancer Lett; 1988 Jun; 40(2):143-9. PubMed ID: 3133107
[TBL] [Abstract][Full Text] [Related]
12. Effects of mitomycin on human colon carcinoma cells.
Long BH; Willson JK; Brattain DE; Musial S; Brattain MG
J Natl Cancer Inst; 1984 Oct; 73(4):787-92. PubMed ID: 6434780
[TBL] [Abstract][Full Text] [Related]
13. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
Lambert PA; Kang Y; Greaves B; Perry RR
J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
Wallner KE; Banda M; Li GC
Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
[TBL] [Abstract][Full Text] [Related]
15. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation.
Dulhanty AM; Li M; Whitmore GF
Cancer Res; 1989 Jan; 49(1):117-22. PubMed ID: 2491748
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance of human multidrug-resistant cells to mitomycin C.
Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T
Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
Dirix LY; Gheuens EE; van der Heyden S; van Oosterom AT; De Bruijn EA
Anticancer Drugs; 1994 Jun; 5(3):343-54. PubMed ID: 7919460
[TBL] [Abstract][Full Text] [Related]
19. Modulation of mitomycin C-induced multidrug resistance in vitro.
Dorr RT; Liddil JD
Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
[TBL] [Abstract][Full Text] [Related]
20. Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.
Satta T; Isobe K; Yamauchi M; Nakashima I; Akiyama S; Itou K; Watanabe T; Takagi H
Jpn J Cancer Res; 1991 May; 82(5):593-8. PubMed ID: 1905705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
